On December 3rd, the Ministry of Industry and Information Technology announced the list of the 2020 National Technological Innovation Demonstration Enterprises. A total of 63 enterprises nationwide were on the list, and only 6 were pharmaceutical enterprises.

Guangzhou Baiyun Mountain and Hutchison Whampoa Ltd. (BMHW) won this title as the only entry from Guangdong pharmaceutical space. It was a high degree of recognition for BMHW’s technological innovation capacity.

On December 4th, the award ceremony for the Science and Technology Award of the Chinese Association of Integrative Medicine (CAIM) was held in Wuhan. This year, 46 awards were announced, including 7 First Prizes, 16 Second Prizes, 20 Third Prizes and 3 Best Practices in Education Awards.

In this year’s selection, the project entitled ‘The application and promotion of Luo’s Gynecopathy’s kidney-nourishing approach for establishing pregnancy and helping maintain a healthy pregnancy’ received the First Prize of the Science and Technology Award of Chinese Association of Integrative Medicine. The project was jointly submitted by the First Affiliated Hospital of Guangdong University of Chinese Medicine, Guangzhou Baiyunshan Zhongyi Pharmaceutical Company Limited and Sun Yat-sen Memorial Hospital, Sun Yat-sen University. This project has made breakthroughs in both theoretical innovation and technological innovation, so has the application of Zishen Yutai Pills (‘zishen’ means ‘tonifying kidney’ and ‘yutai’ means ‘nourishing fetus’) in helping women get pregnant and maintain a healthy pregnancy based on relevant theory and skills.

On December 4th, the 20th the China Drugstore Forum held a grand opening ceremony in Qingdao, Shandong. In the event, the ‘Pharmacists’ Picks of China 2019-2020’ were announced and many leading brands won awards. As one of the winners, the Baiyunshan Fufangdanshen Tablets have received such a title for seven consecutive years. In addition, this was another industry recognition it gained after winning the ‘China Brands with Most Growth Potential Award’.

As a cardio-/cerebrovascular brand, the Baiyunshan Fufangdanshen Tablet with more than 50% market share is one of the most reliable drugs among patients and the most recommended drugs among pharmacists in its category. Clinical trials show that this drug can treat cognitive decline and amnesia caused by blood clots in brain. It can also help patients with vascular dementia resume cognition, language, behaviour and daily living skills.

Authors: Monica & Michelle

Editors: Olivia & Jerry